Pharmafile Logo
Pharmafocus logo
Advanced Search

Norgine quits ABPI and denounces big pharma bias

pharmafile | October 6, 2008 | News story | Sales and Marketing |  ABPI, Norgine 

Related Content

Norgine enters exclusive licensing agreement with Vir Biotechnology

Norgine has announced its exclusive licensing agreement with Vir Biotechnology, under which Norgine will commercialise …

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

The Gateway to Local Adoption Series

Latest content

MHRA approves first lower-carbon beclometasone inhalers for asthma

July 24, 2026

Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide

July 23, 2026

Novogenia breaks ground on personalised healthcare campus

July 23, 2026

InfectoPharm launches Polish operations with first hospital antibiotic

July 22, 2026

FibroFind appoints Lee Borthwick as CEO

July 21, 2026